Table 4 Continuous variable descriptive statistics.
From: An efficacy evaluation method for non-normal outcomes in randomized controlled trials
Centre | Continuous | Treatment | Control | Treatment | Control | ||
|---|---|---|---|---|---|---|---|
Mean | Sd | Mean | Sd | Median | Median | ||
1 | age | 56.39 | 7.48 | 58.90 | 8.37 | 53.00 | 58.00 |
bmi | 23.57 | 1.67 | 23.44 | 1.72 | 23.92 | 23.13 | |
ADAS1 | 12.36 | 4.99 | 12.03 | 6.91 | 13.00 | 12.70 | |
ADASCHA | 2.60 | 2.00 | 2.18 | 2.11 | 2.40 | 2.00 | |
2 | age | 66.00 | 7.60 | 66.75 | 8.30 | 67.50 | 67.50 |
bmi | 23.82 | 1.33 | 22.71 | 3.62 | 23.84 | 22.70 | |
ADAS1 | 8.08 | 3.78 | 8.25 | 3.52 | 7.30 | 8.00 | |
ADASCHA | 2.63 | 3.19 | 4.68 | 3.30 | 2.55 | 5.00 | |
3 | age | 64.25 | 6.41 | 62.63 | 7.39 | 64.00 | 61.00 |
bmi | 24.00 | 2.60 | 24.29 | 2.47 | 24.24 | 23.94 | |
ADAS1 | 17.70 | 5.57 | 18.53 | 5.63 | 17.00 | 19.15 | |
ADASCHA | 5.68 | 3.45 | 4.86 | 4.16 | 4.87 | 4.55 | |
4 | age | 64.88 | 7.92 | 64.50 | 9.02 | 66.50 | 63.50 |
bmi | 24.68 | 2.53 | 24.85 | 2.66 | 24.97 | 24.37 | |
ADAS1 | 20.71 | 6.49 | 21.11 | 5.76 | 19.65 | 20.85 | |
ADASCHA | 4.22 | 3.31 | 6.55 | 6.12 | 4.14 | 5.55 | |
5 | age | 65.71 | 9.07 | 60.75 | 6.77 | 66.00 | 59.50 |
bmi | 24.16 | 2.50 | 25.64 | 2.62 | 24.49 | 26.02 | |
ADAS1 | 18.39 | 5.52 | 17.91 | 5.13 | 19.33 | 19.35 | |
ADASCHA | 4.53 | 3.63 | 4.91 | 1.43 | 4.37 | 5.05 | |
6 | age | 64.63 | 7.55 | 67.83 | 6.55 | 66.00 | 69.00 |
bmi | 24.55 | 3.27 | 23.84 | 3.09 | 24.57 | 23.80 | |
ADAS1 | 10.55 | 4.75 | 10.87 | 3.37 | 9.40 | 10.30 | |
ADASCHA | 3.94 | 4.46 | 4.59 | 3.33 | 3.64 | 4.00 | |
7 | age | 58.17 | 5.95 | 57.42 | 4.87 | 57.50 | 56.00 |
bmi | 22.69 | 1.99 | 22.96 | 2.80 | 22.99 | 22.23 | |
ADAS1 | 15.69 | 5.84 | 14.66 | 3.60 | 14.85 | 14.95 | |
ADASCHA | 3.21 | 6.69 | 2.78 | 5.06 | 4.70 | 3.80 | |
8 | age | 61.81 | 6.96 | 67.63 | 9.54 | 60.00 | 70.50 |
bmi | 23.45 | 3.48 | 23.77 | 3.59 | 22.66 | 23.14 | |
ADAS1 | 14.09 | 5.07 | 15.41 | 5.77 | 15.30 | 14.55 | |
ADASCHA | 3.67 | 3.49 | 2.41 | 2.70 | 2.60 | 1.45 | |
